Hydroxychloroquine for the Prevention of Covid-19 - Searching for Evidence

doi:10.1056/NEJMe2020388

Editorial

. 2020 Aug 6;383(6):585-586.

doi: 10.1056/NEJMe2020388. Epub 2020 Jun 3.

Hydroxychloroquine for the Prevention of Covid-19 - Searching for Evidence

Myron S Cohen¹

Affiliations

PMID: 32492298
PMCID: PMC7289275
DOI: 10.1056/NEJMe2020388

Editorial

Hydroxychloroquine for the Prevention of Covid-19 - Searching for Evidence

Myron S Cohen. N Engl J Med. 2020.

. 2020 Aug 6;383(6):585-586.

doi: 10.1056/NEJMe2020388. Epub 2020 Jun 3.

Author

Myron S Cohen¹

Affiliation

¹ From the Institute for Global Heath and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill.

PMID: 32492298
PMCID: PMC7289275
DOI: 10.1056/NEJMe2020388

No abstract available

PubMed Disclaimer

Comment on

A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.
Boulware DR, Pullen MF, Bangdiwala AS, Pastick KA, Lofgren SM, Okafor EC, Skipper CP, Nascene AA, Nicol MR, Abassi M, Engen NW, Cheng MP, LaBar D, Lother SA, MacKenzie LJ, Drobot G, Marten N, Zarychanski R, Kelly LE, Schwartz IS, McDonald EG, Rajasingham R, Lee TC, Hullsiek KH. Boulware DR, et al. N Engl J Med. 2020 Aug 6;383(6):517-525. doi: 10.1056/NEJMoa2016638. Epub 2020 Jun 3. N Engl J Med. 2020. PMID: 32492293 Free PMC article. Clinical Trial.

Cited by

Potential therapeutic effects and nano-based delivery systems of mesenchymal stem cells and their isolated exosomes to alleviate acute respiratory distress syndrome caused by COVID-19.
Ghiasi M, Kheirandish Zarandi P, Dayani A, Salimi A, Shokri E. Ghiasi M, et al. Regen Ther. 2024 Apr 16;27:319-328. doi: 10.1016/j.reth.2024.03.015. eCollection 2024 Dec. Regen Ther. 2024. PMID: 38650667 Free PMC article. Review.
Personal rights over public Health: Anti-vaccine rhetoric in the Texas Legislature.
Matthews KRW, Lakshmanan R, Kalakuntla N, Tallapragada N. Matthews KRW, et al. Vaccine X. 2024 Feb 28;18:100468. doi: 10.1016/j.jvacx.2024.100468. eCollection 2024 Jun. Vaccine X. 2024. PMID: 38450107 Free PMC article.
The practice of using repurposed medications as chemoprophylaxis for COVID-19 by healthcare workers in a tertiary hospital in Southern Nigeria.
Udoette SB, Onukak AE, Umoh VA, Akpabio AA. Udoette SB, et al. Afr Health Sci. 2023 Sep;23(3):406-411. doi: 10.4314/ahs.v23i3.47. Afr Health Sci. 2023. PMID: 38357117 Free PMC article.
The practice of using repurposed medications as chemoprophylaxis for COVID-19 by healthcare workers in a tertiary hospital in Southern Nigeria.
Udoette SB, Onukak AE, Umoh VA, Akpabio AA. Udoette SB, et al. Afr Health Sci. 2023 Jun;23(2):37-42. doi: 10.4314/ahs.v23i2.5. Afr Health Sci. 2023. PMID: 38223590 Free PMC article.
Simultaneous LC-MS/MS method for the quantitation of Azithromycin, Hydroxychloroquine and its metabolites in SARS-CoV-2(-/ +) populations using dried blood spots.
Chhonker YS, Aldhafiri WN, Soni D, Trivedi N, Steinbronn C, Johnson C, Karita HCS, Paasche-Orlow MK, Barnabas R, Arnold SL, Murry DJ. Chhonker YS, et al. Sci Rep. 2023 Sep 30;13(1):16428. doi: 10.1038/s41598-023-43185-9. Sci Rep. 2023. PMID: 37777555 Free PMC article.

See all "Cited by" articles

References

1. Cohen MS, Corey L. Combination prevention for COVID-19. Science 2020;368:551-551. - PubMed
1. Rolain J-M, Colson P, Raoult D. Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century. Int J Antimicrob Agents 2007;30:297-308. - PMC - PubMed
1. Yao T-T, Qian J-D, Zhu W-Y, Wang Y, Wang G-Q. A systematic review of lopinavir therapy for SARS coronavirus and MERS coronavirus — a possible reference for coronavirus disease-19 treatment option. J Med Virol 2020;92:556-563. - PMC - PubMed
1. Hernandez AV, Roman YM, Pasupuleti V, Barboza JJ, White CM. Hydroxychloroquine or chloroquine for treatment or prophylaxis of COVID-19: a living systematic review. Ann Intern Med 2020. May 27 (Epub ahead of print). - PubMed
1. Boulware DR, Pullen MF, Bangdiwala AS, et al. A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19. N Engl J Med. DOI: 10.1056/NEJMoa2016638. - DOI - PMC - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources

[1] Cohen MS, Corey L. Combination prevention for COVID-19. Science 2020;368:551-551. - PubMed

[2] Cohen MS, Corey L. Combination prevention for COVID-19. Science 2020;368:551-551. - PubMed

[3] Rolain J-M, Colson P, Raoult D. Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century. Int J Antimicrob Agents 2007;30:297-308. - PMC - PubMed

[4] Rolain J-M, Colson P, Raoult D. Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century. Int J Antimicrob Agents 2007;30:297-308. - PMC - PubMed

[5] Yao T-T, Qian J-D, Zhu W-Y, Wang Y, Wang G-Q. A systematic review of lopinavir therapy for SARS coronavirus and MERS coronavirus — a possible reference for coronavirus disease-19 treatment option. J Med Virol 2020;92:556-563. - PMC - PubMed

[6] Yao T-T, Qian J-D, Zhu W-Y, Wang Y, Wang G-Q. A systematic review of lopinavir therapy for SARS coronavirus and MERS coronavirus — a possible reference for coronavirus disease-19 treatment option. J Med Virol 2020;92:556-563. - PMC - PubMed

[7] Hernandez AV, Roman YM, Pasupuleti V, Barboza JJ, White CM. Hydroxychloroquine or chloroquine for treatment or prophylaxis of COVID-19: a living systematic review. Ann Intern Med 2020. May 27 (Epub ahead of print). - PubMed

[8] Hernandez AV, Roman YM, Pasupuleti V, Barboza JJ, White CM. Hydroxychloroquine or chloroquine for treatment or prophylaxis of COVID-19: a living systematic review. Ann Intern Med 2020. May 27 (Epub ahead of print). - PubMed

[9] Boulware DR, Pullen MF, Bangdiwala AS, et al. A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19. N Engl J Med. DOI: 10.1056/NEJMoa2016638. - DOI - PMC - PubMed

[10] Boulware DR, Pullen MF, Bangdiwala AS, et al. A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19. N Engl J Med. DOI: 10.1056/NEJMoa2016638. - DOI - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Hydroxychloroquine for the Prevention of Covid-19 - Searching for Evidence

Affiliation

Hydroxychloroquine for the Prevention of Covid-19 - Searching for Evidence

Author

Affiliation

Comment on

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Comment on

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Related information

LinkOut - more resources

Full Text Sources